LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Karyopharm Therapeutics (NASDAQ: KPTI)

Follow NASDAQ:KPTI Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KPTI Karyopharm Therapeutics
Abate Kristin / officer: Chief Accounting Officer
10/01/2025
Sell
$6.30
362
$2K
10,046
NASDAQ KPTI Karyopharm Therapeutics
Paulson Richard A. / director, officer: President and CEO
09/15/2025
Sell
$6.43
1,257
$8K
84,046
NASDAQ KPTI Karyopharm Therapeutics
Mano Michael / officer: SVP, General Counsel&Secretary
09/15/2025
Sell
$6.43
234
$2K
21,425
NASDAQ KPTI Karyopharm Therapeutics
Poulton Stuart / officer: EVP, Chief Development Officer
09/15/2025
Sell
$6.43
401
$3K
27,710
NASDAQ KPTI Karyopharm Therapeutics
Rangwala Reshma / officer: EVP & Chief Medical Officer
09/15/2025
Sell
$6.43
408
$3K
29,390
NASDAQ KPTI Karyopharm Therapeutics
Cheng Sohanya Roshan / officer: EVP & Chief Commercial Officer
09/15/2025
Sell
$6.43
325
$2K
35,856
NASDAQ KPTI Karyopharm Therapeutics
Abate Kristin / officer: Chief Accounting Officer
09/15/2025
Sell
$6.43
23
$148
10,408
NASDAQ KPTI Karyopharm Therapeutics
Abate Kristin / officer: Chief Accounting Officer
09/03/2025
Sell
$6.78
12
$81
9,463

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous